Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.
暂无分享,去创建一个
Alessandra Bertoldo | Gaia Rizzo | Mattia Veronese | Federico Turkheimer | Philip McGuire | Nicola Kalk | Ilaria Bonoldi | Sudhakar Selvaraj | F. Turkheimer | P. McGuire | O. Howes | M. Veronese | A. Bertoldo | S. Selvaraj | M. Bloomfield | I. Bonoldi | D. Owen | G. Rizzo | N. Kalk | P. Bloomfield | David R Owen | Oliver D Howes | Peter S Bloomfield | Michael Ap Bloomfield | Vincenzo de Paola | V. de Paola
[1] B. Kirkpatrick,et al. Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.
[2] Alessandra Bertoldo,et al. Kinetic Modeling without Accounting for the Vascular Component Impairs the Quantification of [11C]PBR28 Brain PET Data , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Robert B. Innis,et al. PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat , 2007, Neuroscience Letters.
[4] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] O. Howes,et al. Glutamate and dopamine in schizophrenia: An update for the 21st century , 2015, Journal of psychopharmacology.
[6] Kris Thielemans,et al. Correction of head movement on PET studies: comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] Paolo Fusar-Poli,et al. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. , 2013, Schizophrenia bulletin.
[8] Anthonin Reilhac,et al. Simulation-based evaluation of OSEM iterative reconstruction methods in dynamic brain PET studies , 2008, NeuroImage.
[9] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[10] Kimberly J. Jenko,et al. A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Ania K. Majewska,et al. Microglial Interactions with Synapses Are Modulated by Visual Experience , 2010, PLoS biology.
[12] B. Rosen,et al. Evidence for brain glial activation in chronic pain patients. , 2015, Brain : a journal of neurology.
[13] Tyrone D. Cannon,et al. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk , 2015, Biological Psychiatry.
[14] Paul M. Matthews,et al. Eratum: Determination of [ 11 C]PBR28 binding potential in vivo: A first human TSPO blocking study (Journal of Cerebral Blood Flow and Metabolism (2014) 34 (1256)) , 2014 .
[15] H. Neumann,et al. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis , 2014, Journal of Neuroinflammation.
[16] R. Boellaard,et al. Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.
[17] Masahiro Fujita,et al. Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.
[18] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[19] Rudi A. Dierckx,et al. Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.
[20] P. Falkai,et al. Evidence for activation of microglia in patients with psychiatric illnesses , 1999, Neuroscience Letters.
[21] R. Murray,et al. Schizophrenia: an integrated sociodevelopmental-cognitive model , 2014, The Lancet.
[22] B. Bogerts,et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.
[23] Takahiro A. Kato,et al. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-γ , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[24] Yoshiro Okubo,et al. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. , 2010, The international journal of neuropsychopharmacology.
[25] Yu-Qiang Ding,et al. Minocycline and Risperidone Prevent Microglia Activation and Rescue Behavioral Deficits Induced by Neonatal Intrahippocampal Injection of Lipopolysaccharide in Rats , 2014, PloS one.
[26] Satoshi O. Suzuki,et al. Inhibitory effects of aripiprazole on interferon‐γ‐induced microglial activation via intracellular Ca2+ regulation in vitro , 2008, Journal of neurochemistry.
[27] L. Sansing,et al. Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage , 2013, Clinical & developmental immunology.
[28] S. Shapiro,et al. An Analysis of Variance Test for Normality (Complete Samples) , 1965 .
[29] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[30] A. Yung,et al. Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .
[31] Roger N Gunn,et al. An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] U Hegerl,et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. , 2001, The American journal of psychiatry.
[33] Jennifer M. Coughlin,et al. Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV , 2014, Journal of NeuroVirology.
[34] R. Butterworth,et al. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. , 1997, European journal of pharmacology.
[35] A. Gee,et al. The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. , 2003, Nuclear medicine and biology.
[36] Richard E. Carson,et al. Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates , 2012, NeuroImage.
[37] L. Garey,et al. Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.
[38] E. Madarász,et al. Translocator protein (TSPO 18kDa) is expressed by neural stem and neuronal precursor cells , 2009, Neuroscience Letters.
[39] M. Kempton,et al. Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk , 2013 .
[40] M. First,et al. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.
[41] F. Turkheimer,et al. Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging , 2008, Schizophrenia Research.
[42] J. Trojanowski,et al. In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders , 2011, The Journal of Neuroscience.
[43] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] Peter Herscovitch,et al. Propofol Decreases In Vivo Binding of 11C-PBR28 to Translocator Protein (18 kDa) in the Human Brain , 2013, The Journal of Nuclear Medicine.
[45] Frederik Barkhof,et al. Microglial activation in healthy aging , 2012, Neurobiology of Aging.
[46] R. Parkkola,et al. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195 , 2014, The Journal of Nuclear Medicine.
[47] H. Möller,et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. , 2002, The American journal of psychiatry.
[48] Mark Jenkinson,et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.
[49] O. J. Dunn. Multiple Comparisons among Means , 1961 .
[50] M. Yücel,et al. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. , 2007, Schizophrenia bulletin.
[51] Annelaure Damont,et al. Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] P. Mcguire,et al. Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis , 2013, European Psychiatry.
[53] Tyrone D. Cannon,et al. Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project , 2014, Schizophrenia bulletin.
[54] I. Duncan,et al. 11C-(R)-PK11195 PET Imaging of Microglial Activation and Response to Minocycline in Zymosan-Treated Rats , 2011, The Journal of Nuclear Medicine.